Contraceptive practices of non-HIV-seropositive injecting drug users

European Journal of Epidemiology

Volumn 18, Issue 9, 2003, Pages 863-869

  Vidal Trecan, Gwenaelle ^a   Warszawski, Josiane ^b   Coste, Joel ^a   Bajos, Nathalie ^d   Delamare, Natalie ^a   Grenier Sennelier, Catherine ^a   Boissonnas, Alain ^c  

^a université Paris Cité   (France)

^b BICÊTRE HOSPITAL   (France)

^c HÔPITAL PAUL BROUSSE   (France)

^d Universite Rene Descartes Paris V ^*

Author keywords

Condoms; Intravenous; Sex behaviour; Substance abuse

Indexed keywords

ADULT; ARTICLE; CONDOM; CONTRACEPTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; SELF REPORT; SEXUAL BEHAVIOR;

ADULT; CONDOMS; CONTRACEPTION; CONTRACEPTIVES, ORAL; DEMOGRAPHY; FEMALE; HIV SERONEGATIVITY; HUMANS; INTRAUTERINE DEVICES; MALE; MARITAL STATUS; PARIS; QUESTIONNAIRES; RISK-TAKING; SEX FACTORS; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0141793135     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025643421939     Document Type: Article

References (25)

1. Cates W Jr. Contraception, unintended pregnancies, and sexually transmitted diseases: Why isn't a simple solution possible? Am J Epidemiol 1996; 143(4): 311-318.
2. Cates W Jr, Stone KM. Family planning, sexually transmitted diseases and contraceptive choice: A literature update - Part I [see comments]. Fam Plann Perspect 1992; 24(2): 75-84.
3. Fraser AC. Drug addiction in pregnancy. Lancet 1976; 2(7991): 896-899.
4. Donoghoe MC. Sex, HIV and the injecting drug user. Br J Addict 1992; 87(3): 405-416.
5. Vidal-Trecan G, Coste J, Varescon-Pousson I, Reboul-Marty J, Christoforov B, Boissonnas A. Patterns of sexual and injecting risk behaviours in French intravenous drug users not reporting HIV and hepatitis C virus seropositivities. Addiction 1998; 93(11): 1657-1668.
6. Ralph N, Spigner C. Contraceptive practices among female heroin addicts. Am J Public Health 1986; 76(8): 1016-1017.
7. Murphy D, Lynch M, Desmond N, Mulcahy FM. Contraceptive practices in HIV seropositive females in Ireland. Int J STD AIDS 1993; 4(2): 107-109.
8. Baqi S, Nabi N, Hasan SN, et al. HIV antibody seroprevalence and associated risk factors in sex workers, drug users, and prisoners in Sindh, Pakistan. J Acq Imm Def Synd Human Retrovirol 1998; 18(1): 73-79.
9. Watters JK. Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992. J Acq imm Def Synd 1994; 7(12): 1276-1281.
10. Boissonnas A, Vidal-Trecan G, Coste J, Varescon-Pousson I, Reboul-Marty J. Les Comportements à Risque des Toxicomanes [Intravenous Drug Users Risk Behaviours]. Sèvres: Editions médicales et scientifiques EDK, 1996: 95pp.
11. Spira A, Bajos N, le groupe ACSF. Les Comportements Sexuels en France [Sexual Behaviors in France]. Paris: Collection des rapports officiels; La documentation française, 1993: 351pp.
12. Warszawski J, Messiah A, Lellouch J, Meyer L, Deville JC. Estimating means and percentages in a complex sampling survey: Application to a French national survey on sexual behaviour (ACSF). Analyse des Comportements Sexuels en France. Stat Med 1997; 16(4): 397-423.
13. Fu H, Darroch JE, Haas T, Ranjit N. Contraceptive failure rates: New estimates from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999; 31(2): 56-63.
14. Oddens BJ. Determinants of contraceptive use among women of reproductive age in Great Britain and Germany. II: Psychological factors. J Biosoc Sci 1997; 29(4): 437-470.
15. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis. Lancet 2001; 357(9266): 1397-1401.
16. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996; 86(5): 655-661.
17. Calsyn DA, Saxon AJ, Freeman G Jr, Whittaker S. Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. Am J Public Health 1992; 82(4): 573-575.
18. Kamb ML, Fishbein M, Douglas JM Jr, Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: A randomized controlled trial. Project RESPECT Study Group. JAMA 1998; 280(13): 1161-1167.
19. Kenen RH, Armstrong K. The why, when and whether of condom use among female and male drug users. J Commun Health 1992; 17(5): 303-317.
20. Ross MW. Attitudes toward condoms and condom use: A review. Int J STD AIDS 1992; 3(1): 10-16.
21. Cushman LF, Romero D, Kalmuss D, Davidson AR, Heartwell S, Rulin M. Condom use among women choosing long-term hormonal contraception. Fam Plann Perspect 1998; 30(5): 240-243.
22. Messiah A, Dart T, Spencer BE, Warszawski J. Condom breakage and slippage during heterosexual intercourse: A French national survey. French National Survey on Sexual Behavior Group (ACSF). Am J Public Health 1997; 87(3): 421-424.
23. Darke S, Hall W, Heather N, Ward J, Wodak A. The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. AIDS 1991; 5(2): 181-185.
24. McElrath K, Chitwood DD, Griffin DK, Comerford M. The consistency of self-reported HIV risk behavior among injection drug users. Am J Public Health 1994; 84(12): 1965-1970.
25. Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 1993; 88(4): 517-526.